Allogeneic CRISPR-Engineered CAR-T Cells Drive Potent Antitumor Activity in Solid Tumors
Molecular Therapy: Oncology
· Elsevier
Аннотация
Publication date: Available online 18 November 2026 Source: Molecular Therapy Oncology Author(s): Mingyu Huo, Dan Li, Nan Li, Alex Quan, Tianyuzhou Liang, Dan Henderson, Jason Sagert, Minh Pham, Luke Hanley, Kelly Maeng, Mikhala Eule, Mitchell Ho
Читать у издателя →
Цитировать
Получайте новые статьи по теме «Медицинская фармакология»
Подписка, поиск по ключевым словам и избранное — в Telegram-боте Articlium.
Открыть в Telegram
Цитирование
✕
ГОСТ
APA
MLA
BibTeX
Allogeneic CRISPR-Engineered CAR-T Cells Drive Potent Antitumor Activity in Solid Tumors. // Molecular Therapy: Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2950329926002651?dgcid=rss_sd_all
Allogeneic CRISPR-Engineered CAR-T Cells Drive Potent Antitumor Activity in Solid Tumors. Molecular Therapy: Oncology. https://www.sciencedirect.com/science/article/pii/S2950329926002651?dgcid=rss_sd_all
“Allogeneic CRISPR-Engineered CAR-T Cells Drive Potent Antitumor Activity in Solid Tumors.” Molecular Therapy: Oncology.
@article{article101012,
title = {Allogeneic CRISPR-Engineered CAR-T Cells Drive Potent Antitumor Activity in Solid Tumors},
journal = {Molecular Therapy: Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2950329926002651?dgcid=rss_sd_all}
}